IP Library Granted Patent US 9,410,172
Granted Patent B2
US 9,410,172 · App. 14/027,947 · Granted Aug 9, 2016

Isothermal amplification using oligocation-conjugated primer sequences

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,410,172
App. No.
14/027,947
Granted
Aug 9, 2016
Kind
B2
Abstract

Provided herein are methods and kits for isothermal nucleic acid amplifications that use an oligocation-oligonucleotide conjugate primer for amplifying a target nucleic acid to generate amplicons. Isothermal DNA amplification methods that employ a strand displacing DNA polymerase and polyamine-oligonucleotide conjugate primer are also provided.

Claims (18)

1. A method for producing at least one amplicon based on a target DNA, the method comprising:

(a) providing the target DNA;

(b) providing a DNA amplification reaction mixture comprising an oligocation-oligonucleotide conjugate primer, a DNA polymerase having a strand displacement activity, and a dNTP mixture; and

(c) amplifying at least one portion of the target DNA using the DNA amplification reaction mixture of step (b) to produce the at least one amplicon,

wherein the oligocation-oligonucleotide conjugate primer comprises an oligocation moiety covalently conjugated to the 5′ end of an oligonucleotide sequence wherein the oligocation moiety comprises at least one lysine moiety, and

wherein the amplification is performed under isothermal conditions.

2. The method of claim 1 , wherein the oligocation moiety is a cationic polyamine.

3. The method of claim 2 , wherein the oligonucleotide sequence is a random oligonucleotide sequence or a partially constrained oligonucleotide sequence.

4. The method of claim 3 , wherein the oligonucleotide sequence comprises a nucleotide analogue.

5. The method of claim 3 , wherein the oligonucleotide sequence comprises a phosphorothioate linkage between a 3 ′ terminal nucleotide and a nucleotide that is adjacent to the 3′ terminal nucleotide.

6. The method of claim 5 , wherein the oligonucleotide sequence is NNNNN*N.

7. A method of producing at least one amplicon based on a target DNA comprising:

providing the target DNA;

annealing at least one oligocation-oligonucleotide conjugate primer to the target DNA to generate a target DNA:primer hybrid; and

extending the oligocation-oligonucleotide conjugate primer in the target DNA:primer hybrid via an isothermal nucleic acid amplification reaction to produce the at least one amplicon complementary to at least one portion of the target DNA,

wherein the oligocation-oligonucleotide conjugate primer comprises an oligocation moiety covalently conjugated to the 5′ end of an oligonucleotide sequence and wherein the oligocation moiety comprises at least one lysine moiety.

8. The method claim 7 , wherein the isothermal nucleic acid amplification is multiple strand displacement nucleic acid amplification or rolling circle amplification.

9. The method of claim 7 , wherein the oligocation-oligonucleotide conjugate primer comprises a random pentamer sequence or a random hexamer sequence.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2020
From: GE HEALTHCARE UK LIMITED
To: GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LTD
Reel/Frame 054300/0369 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2020
From: GENERAL ELECTRIC COMPANY
To: GE HEALTHCARE UK LIMITED
Reel/Frame 053981/0329 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2014
From: HELLER, RYAN CHARLES; NELSON, JOHN RICHARD
To: GENERAL ELECTRIC COMPANY
Reel/Frame 032563/0977 →